Clinical Features of Adult COVID-19 Patients without Risk Factors before and after the Nationwide SARS-CoV-2 B.1.617.2 (Delta)-variant Outbreak in Korea : Experience from Gyeongsangnam-do
© 2021 The Korean Academy of Medical Sciences..
BACKGROUND: Data on severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) delta variant virulence are insufficient. We retrospectively compared the clinical features of adult coronavirus disease 2019 (COVID-19) patients without risk factors for severe COVID-19 who entered residential treatment centers (RTCs) before and after the delta variant outbreak.
METHODS: We collected medical information from two RTCs in South Korea. On the basis of nationwide delta variant surveillance, we divided the patients into two groups: 1) the delta-minor group (diagnosed from December 2020-June 2021, detection rate < 10%) and 2) the delta-dominant group (diagnosed during August 2021, detection rate > 90%). After propensity-score matching, the incidences of pneumonia, hospital transfer and need for supplemental oxygen were compared between the groups. In addition, risk factors for hospital transfer were analysed.
RESULTS: A total of 1,915 patients were included. The incidence of pneumonia (14.6% vs. 9.2%, P = 0.009), all-cause hospital transfer (10.4% vs. 6.3%, P = 0.020) and COVID-19-related hospital transfer (7.5% vs. 4.8%, P = 0.081) were higher in the delta-dominant group than those in the delta-minor group. In the multivariate analysis, the delta-dominant group was an independent risk factor for all-cause (adjusted odds ratio [aOR], 1.91; 95% confidence interval [CI], 1.16-3.13; P = 0.011) and COVID-19-related hospital transfer (aOR, 1.86; 95% CI, 1.04-3.32; P = 0.036).
CONCLUSION: Hospitalization rates were increased in the adult COVID-19 patients during the delta variant nationwide outbreak. Our results showed that the delta variant may be more virulent than previous lineages.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
Journal of Korean medical science - 36(2021), 49 vom: 20. Dez., Seite e341 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ryu, Byung-Han [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 07.01.2022 Date Revised 04.04.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3346/jkms.2021.36.e341 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM334675154 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM334675154 | ||
003 | DE-627 | ||
005 | 20240404233723.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3346/jkms.2021.36.e341 |2 doi | |
028 | 5 | 2 | |a pubmed24n1364.xml |
035 | |a (DE-627)NLM334675154 | ||
035 | |a (NLM)34931500 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ryu, Byung-Han |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical Features of Adult COVID-19 Patients without Risk Factors before and after the Nationwide SARS-CoV-2 B.1.617.2 (Delta)-variant Outbreak in Korea |b Experience from Gyeongsangnam-do |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.01.2022 | ||
500 | |a Date Revised 04.04.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 The Korean Academy of Medical Sciences. | ||
520 | |a BACKGROUND: Data on severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) delta variant virulence are insufficient. We retrospectively compared the clinical features of adult coronavirus disease 2019 (COVID-19) patients without risk factors for severe COVID-19 who entered residential treatment centers (RTCs) before and after the delta variant outbreak | ||
520 | |a METHODS: We collected medical information from two RTCs in South Korea. On the basis of nationwide delta variant surveillance, we divided the patients into two groups: 1) the delta-minor group (diagnosed from December 2020-June 2021, detection rate < 10%) and 2) the delta-dominant group (diagnosed during August 2021, detection rate > 90%). After propensity-score matching, the incidences of pneumonia, hospital transfer and need for supplemental oxygen were compared between the groups. In addition, risk factors for hospital transfer were analysed | ||
520 | |a RESULTS: A total of 1,915 patients were included. The incidence of pneumonia (14.6% vs. 9.2%, P = 0.009), all-cause hospital transfer (10.4% vs. 6.3%, P = 0.020) and COVID-19-related hospital transfer (7.5% vs. 4.8%, P = 0.081) were higher in the delta-dominant group than those in the delta-minor group. In the multivariate analysis, the delta-dominant group was an independent risk factor for all-cause (adjusted odds ratio [aOR], 1.91; 95% confidence interval [CI], 1.16-3.13; P = 0.011) and COVID-19-related hospital transfer (aOR, 1.86; 95% CI, 1.04-3.32; P = 0.036) | ||
520 | |a CONCLUSION: Hospitalization rates were increased in the adult COVID-19 patients during the delta variant nationwide outbreak. Our results showed that the delta variant may be more virulent than previous lineages | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Observational Study | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Delta Variant | |
650 | 4 | |a Hospitalization | |
650 | 4 | |a South Korea | |
650 | 4 | |a Virulence | |
700 | 1 | |a Hong, Sun In |e verfasserin |4 aut | |
700 | 1 | |a Lim, Su Jin |e verfasserin |4 aut | |
700 | 1 | |a Cho, Younghwa |e verfasserin |4 aut | |
700 | 1 | |a Hwang, Cheolgu |e verfasserin |4 aut | |
700 | 1 | |a Kang, Hyungseok |e verfasserin |4 aut | |
700 | 1 | |a Kim, Si-Ho |e verfasserin |4 aut | |
700 | 1 | |a Wi, Yu Mi |e verfasserin |4 aut | |
700 | 1 | |a Hong, Kyung-Wook |e verfasserin |4 aut | |
700 | 1 | |a Bae, In-Gyu |e verfasserin |4 aut | |
700 | 1 | |a Cho, Oh-Hyun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of Korean medical science |d 1995 |g 36(2021), 49 vom: 20. Dez., Seite e341 |w (DE-627)NLM012649317 |x 1598-6357 |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2021 |g number:49 |g day:20 |g month:12 |g pages:e341 |
856 | 4 | 0 | |u http://dx.doi.org/10.3346/jkms.2021.36.e341 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2021 |e 49 |b 20 |c 12 |h e341 |